Pancragen 20 mg – Peptide Hubs
Pancragen is an organ-specific peptide complex designed to support pancreatic health, insulin signaling, and beta-cell activity. Derived from natural cytomedin peptides targeting the pancreas, Pancragen may regulate gene expression, enhance tissue repair, and support glucose metabolism in research settings. Peptide Hubs provides Pancragen in a 20 mg lyophilized format suitable for advanced metabolic and endocrine research.
Mechanism of Action
Pancragen's mechanism focuses on restoring pancreatic tissue function at the molecular level. The short peptides in Pancragen bind to nuclear structures and modulate gene expression, potentially enhancing insulin production and protecting beta cells. This mechanism aligns with cytogenetic peptide research as discussed in this NIH article on peptide bioregulators.
Primary Research Applications
- Pancreatic regeneration and beta-cell support studies
- Insulin pathway modulation research
- Preclinical models of diabetes and metabolic syndrome
- Endocrine and glucose regulation studies
Pancragen is frequently combined with Semaglutide or MOTS-c in research focused on metabolic and glycemic regulation. For oxidative stress and mitochondrial protection, Humanin is a common stack. DNA integrity and cellular repair models may also include FOX04-DRI or L-Glutathione.
Suggested Experimental Use
- Dosage: 20–40 mg per week (e.g. 10 mg 2–4x/week)
- Administration: Subcutaneous injection in preclinical settings
- Duration: Typically 4–6 weeks in pancreas-focused protocols
Technical Details
Peptide Type
Synthetic Linear Tetrapeptide
Peptide Sequence
Lys-Glu-Asp-Trp (KEDW)
Peptide Length
4 Amino-Acid Residues
Terminal Form
H-Lys-Glu-Asp-Trp-OH
Molecular Formula
CββHββNβOβ
Molecular Weight
578.62 g/mol
Research Status
Experimental / Preclinical
Dosage & Usage Guidelines
- Semaglutide – GLP-1 pathway synergy
- Humanin – mitochondrial and beta-cell protection
- MOTS-c – metabolic resilience and energy balance
- L-Glutathione – antioxidant and DNA support
Legal Disclaimer
Pancragen is not approved by the FDA and is intended for research purposes only. No androgenic, estrogenic, or hepatotoxic effects have been reported in preclinical data. Proper storage and handling protocols should be followed as per institutional guidelines.
Shipping & Product Authenticity
USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Direct Supply & Discreet Delivery
This product is supplied through the official Peptide Hubs distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
What to Expect
- β Orders are processed after payment confirmation
- β USA Domestic shipping is typically faster when local stock is selected
- β International orders include tracking, though update frequency may vary by destination
- β Multiple warehouses may result in separate shipments when applicable
Authenticity support: official Peptide Hubs presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
Verified Supply
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.
After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices during research use.
Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.
Frequently Asked Questions
What is Pancragen used for in research?
Pancragen is studied for its role in pancreatic tissue repair, insulin signaling, and beta-cell function support in models of metabolic dysfunction.
Does Pancragen affect insulin production?
Research suggests Pancragen may help support insulin gene expression and pancreatic beta-cell recovery, though it is not a replacement for insulin itself.
Can Pancragen be stacked with GLP-1 agonists?
Yes. It is often stacked with compounds like Semaglutide or MOTS-c in studies related to glucose homeostasis and insulin sensitivity.
Is Pancragen FDA approved?
No. Pancragen is not FDA-approved. It is intended for laboratory use only and is not sold for human or veterinary administration.
No reviews found
Please log in to write Pancragen 20 mg review.